Ombitasvir

CHEMBL3127326 Phase 4 Approved Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

894.1 g/mol

LogP

7.9

Phase

4

An antiviral medication used in combination regimens to treat chronic hepatitis C infection by blocking a protein the virus needs to replicate. It is always used with other antiviral drugs to achieve a cure and prevent liver damage.

Molecular Weight

894.1000 g/mol

LogP

7.90

TPSA

179.00 Å²

Lipinski RO5

Fail

Therapeutic Areas

Hepatitis C

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure

Embed this structure

SMILES

COC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1ccc([C@@H]2CC[C@@H](c3ccc(NC(=O)[C@@H]4CCCN4C(=O)[C@@H](NC(=O)OC)C(C)C)cc3)N2c2ccc(C(C)(C)C)cc2)cc1)C(C)C

InChI

InChI=1S/C50H67N7O8/c1-30(2)42(53-48(62)64-8)46(60)55-28-10-12-40(55)44(58)51-35-20-14-32(15-21-35)38-26-27-39(57(38)37-24-18-34(19-25-37)50(5,6)7)33-16-22-36(23-17-33)52-45(59)41-13-11-29-56(41)47(61)43(31(3)4)54-49(63)65-9/h14-25,30-31,38-43H,10-13,26-29H2,1-9H3,(H,51,58)(H,52,59)(H,53,62)(H,54,63)/t38-,39-,40-,41-,42-,43-/m0/s1

Molecular Formula

C50H67N7O8

HBD / HBA

4 / 9

Rotatable Bonds

16

Heavy Atoms

65

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

An antiviral medication used in combination regimens to treat chronic hepatitis C infection by blocking a protein the virus needs to replicate. It is always used with other antiviral drugs to achieve a cure and prevent liver damage.

Yes, Ombitasvir is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3127326. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 54767916. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Looking for patient-friendly information?

Ombitasvir on PillFYI

Structure

Quick Data

Formula: C50H67N7O8

External Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.